Scientific Program

Abstract:

CMV is the most frequent congenital infection and has a UK incidence of around 3-4/1000 live births. Around 10-15% of these infants will be symptomatic, of whom up to 90% will develop long term sequelae usually in the form of sensorineural hearing loss, visual impairment, or developmental delay. Some 13% of asymptomatic infants also develop long term problems. Despite such morbidity, decisions of whom to treat, and for how long, remain controversial.

Audience Take Away

• Objectives of session: Whilst there is some support for treating infants with CNS symptoms, there is a paucity of high-level evidence for treating infants with other organ involvement
• In addition, the adverse effects of treatment are not inconsiderable
• Thus the talk will aim to address these dilemmas and help the participants develop an evidence-based management approach

Biography:

Rohit Kumar is a consultant neonatologist based in a tertiary referral center, where he holds the position of Clinical Lead for Risk Management and Infectious Disease. Additionally, Rohit serves as the Neonatal Representative at the Regional Transfusion Medicine Committee and the Intrapartum Care Group. With a wealth of experience, Rohit has presented at numerous international conferences and contributed to reputable peer-reviewed journals. His dedication to neonatal care and active involvement in committees underscores his commitment to advancing the field.